阿托伐他汀钙对冠心病心功能不全患者肾功能的保护作用被引量：20

下载PDF

导出

摘要目的探讨在常规心功能不全治疗基础上加用阿托伐他汀钙对冠心病心功能不全患者肾功能的保护作用。方法选取128例冠心病心功能不全患者,分别对肾功能指标肾小球滤过率(GFR)、β2微球蛋白(β2MG)和胱抑素(CysC)正常(64例)和异常(64例)患者设常规治疗对照组和加用阿托伐他汀钙治疗观察组,对照组按常规心功能不全药物治疗,观察组在此基础上加用阿托伐他汀钙20 mg/次,1次/d。分别于治疗前、治疗6个月和12个月时测定患者肾功能指标GFR、β2MG和CysC,并统计肾功能指标变化的差异。结果肾功能正常患者观察组与对照组肾功能指标GFR和β2MG治疗前后差异无统计学意义(P>0.05),CysC治疗前和治疗6个月后差异无统计学意义(P>0.05),治疗12个月后差异有统计学意义(P<0.01);肾功能异常患者观察组与对照组肾功能指标β2MG治疗前后变化无统计学意义(P>0.05),CysC治疗6个月和12个月差异有统计学意义(P<0.01),GFR治疗6个月差异无统计学意义(P>0.05),12个月差异有统计学意义(P<0.01)。结论阿托伐他汀钙对于冠心病心功能不全患者有一定的肾保护作用,这种保护作用首先表现在指标CysC上。

作者陈秋霞熊龙根

机构地区广州医学院第五附属医院心血管内科广州医学院第二附属医院心内科

出处《广东医学》 CAS CSCD 北大核心 2012年第12期1827-1829,共3页 Guangdong Medical Journal

关键词阿托伐他汀钙冠心病肾功能心功能不全

分类号 R589.2 [医药卫生—内分泌]

引文网络
相关文献

参考文献13

1HILLEGE H L, NITSCH D, PFEFFER M A, et al. Renal func- tion as a predictor of outcome in a broad spectrum of patients with heart failure[J]. Circulation, 2006, 113(5) : 671 -678.
2杨艳华,王林,安芳,黄姣红,马金萍,李广平,李立丰.肾功能不全对慢性心力衰竭住院患者预后影响的回顾性分析[J].中华心血管病杂志,2009,37(8):729-733. 被引量：14
3POCOCK S J, WANG D, PFEFFER M A, et al. Predictors of mortality and morbidity in patients with chronic heart failure [ J ]. Eur Heart J, 2006, 27 ( 1 ) : 65 - 75.
4李航,李学旺.他汀类药物在肾脏病治疗中的作用及机制的研究进展[J].北京医学,2002,24(4):271-272. 被引量：3
5HUNT S A, ABRAHAM W T, CHINA M H, et al. ACC / AHA2005 guideline update for the diagnosis and management of chronic heart failure in the adult [ J ]. J Am Coil Cardiol, 2005, 46(6) : el -e82.
6韩振武,赵然,邵树茂,等.血清胱抑素c用以评估肾小球滤过率的价值[j].中国误诊医学杂志,2007,7(18):4222-4223.
7谢群芳,王叶舟,戴文森.血清胱抑素C清除值估测肾小球滤过率的临床评价[J].中国误诊学杂志,2007,7(9):1969-1970. 被引量：56
8QPEDA F J, FERNANDEZ E, POBES A, et al. Utility of Cystatin -C in hospitalized patients. Comparing with different methods of assessing renal function[J]. Nefrologia, 2007, 37(2) : 168 -174.
9YANG Y S, PENG C H, LIN C K, et al. Use of serum cystatin C to detect early decline of glomerular filtration rate in type2 diabetes[ J]. J Intern Medlntern Med J, 2007, 46 (12) : 801 -806.
10段晓星,张国光,梦雅平.Cystatin C评估慢性肾脏病肾功能的研究[J].内蒙古医学院学报,2010,32(2):87-91. 被引量：4

二级参考文献34

1张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量：369
2谢群芳,王叶舟,戴文森.血清胱抑素C清除值估测肾小球滤过率的临床评价[J].中国误诊学杂志,2007,7(9):1969-1970. 被引量：56
3Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation, 2006, 113: 671-678.
4Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol, 2006, 17: 2937-2944.
5Heywood .IT, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail, 2007, 13 : 422-430.
6Shlipak MG. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med, 2003, 138:917-924.
7Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta- analysis. J Am Coil Cardiol, 2006, 47: 1987-1996.
8Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure. JAMA, 2003, 290 : 2581-2587.
9Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coil Cardiol, 2001, 38:955-962.
10Pocock S J, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J,2006, 27 : 65-75.